相似文献
1
[Individualized therapy in treatment of rheumatic diseases].
Zhonghua Yi Xue Za Zhi. 2006 Sep 19;86(35):2449-50.
2
Drug therapy in the rheumatic diseases.
Compr Ther. 1992 Nov;18(11):22-5.
3
[Aceclofenac (aertal) in rheumatological practice].
Ter Arkh. 2005;77(5):87-90.
4
[Therapy of inflammatory rheumatic diseases: from current practice standards to future].
Internist (Berl). 2001 Feb;42(2):223-32, 234-6. doi: 10.1007/s001080050746.
5
[Can we treat with modern antirheumatics? Costs of NSAID treatment].
Pharm Unserer Zeit. 2002;31(2):206-15. doi: 10.1002/1615-1003(200203)31:2<206::AID-PAUZ206>3.0.CO;2-#.
6
'Compliance' is futile but is 'concordance' between rheumatology patients and health professionals attainable?
Rheumatology (Oxford). 2006 Jan;45(1):1-5. doi: 10.1093/rheumatology/kei223.
7
Pharmacogenetics in the rheumatic diseases, from prêt-à-porter to haute couture.
Nat Clin Pract Rheumatol. 2006 Jan;2(1):2-3. doi: 10.1038/ncprheum0072.
8
Systemic lupus erythematosus.
Am Fam Physician. 2007 Nov 1;76(9):1351-3.
9
Guidelines for use of antirheumatic drugs.
J Rheumatol Suppl. 1994 Sep;41:79-81.
10
Key developments in rheumatology.
Practitioner. 2000 Dec;244(1617):1024-6, 1029-32.
Zotero 插件